<!DOCTYPE html><html lang="zh-Hant"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1.0"><title>研究方法 | V-010</title><link rel="stylesheet" href="css/style.css"></head><body><nav><ul><li><a href="index.html"><span data-lang="zh">首頁</span><span data-lang="en">Home</span></a></li><li><a href="introduction.html"><span data-lang="zh">緒論</span><span data-lang="en">Introduction</span></a></li><li><a href="methodology.html"><span data-lang="zh">方法</span><span data-lang="en">Methodology</span></a></li><li><a href="results.html"><span data-lang="zh">結果</span><span data-lang="en">Results</span></a></li><li><a href="discussion.html"><span data-lang="zh">討論</span><span data-lang="en">Discussion</span></a></li><li><a href="conclusion.html"><span data-lang="zh">結論</span><span data-lang="en">Conclusion</span></a></li><li><a href="appendix.html"><span data-lang="zh">附錄</span><span data-lang="en">Appendix</span></a></li></ul><button id="lang-toggle" onclick="toggleLang()">Switch to EN</button></nav><div class="container">
<h1><span data-lang="zh">研究方法</span><span data-lang="en">Methodology</span></h1>
<h2><span data-lang="zh">2.1 數據來源</span><span data-lang="en">2.1 Data Sources</span></h2>
<div data-lang="zh"><table><tr><th>數據</th><th>來源</th><th>期間</th><th>說明</th></tr><tr><td>台股 PE/PB/殖利率</td><td>FinMind API (30 檔)</td><td>2010-2025</td><td>每季末快照</td></tr><tr><td>台股日線</td><td>FinMind API (30 檔)</td><td>2010-2025</td><td>含除權息調整</td></tr><tr><td>FF 三因子</td><td>Kenneth French 網站</td><td>1926-2025</td><td>月頻率</td></tr></table></div><div data-lang="en"><table><tr><th>Data</th><th>Source</th><th>Period</th><th>Note</th></tr><tr><td>TW PE/PB/Yield</td><td>FinMind API (30 stocks)</td><td>2010-2025</td><td>Quarterly snapshot</td></tr><tr><td>TW Daily Prices</td><td>FinMind API (30 stocks)</td><td>2010-2025</td><td>Dividend-adjusted</td></tr><tr><td>FF 3 Factors</td><td>Kenneth French website</td><td>1926-2025</td><td>Monthly frequency</td></tr></table></div>
<div data-lang="zh"><p><strong>數據品質討論：</strong>台灣數據來自 FinMind 免費版 API，涵蓋市值前 30 大上市公司。免費版可能存在部分日期遺漏或延遲更新的問題，但大型股的資料完整度較高。Fama-French 因子數據來自 Kenneth French 的官方資料庫，被視為學術界的「黃金標準」——全球數千篇論文都使用同一套資料，品質有保障。</p><p><strong>為何選擇雙市場：</strong>僅看台灣市場有兩個問題：(1) 歷史太短（2010 年起），僅約 15 年數據，統計檢定力有限；(2) 台灣市場高度集中於半導體產業（台積電佔加權指數約 30%），可能不具代表性。搭配美國近百年的 Fama-French 數據，可以檢驗台灣的結果是特例還是全球性現象。</p></div><div data-lang="en"><p><strong>Data quality discussion:</strong> Taiwan data comes from FinMind free API covering the top 30 listed companies. The free tier may have occasional date gaps or delayed updates, but large-cap data tends to be more complete. Fama-French factor data comes from Kenneth French official database, considered the "gold standard" in academia — thousands of papers globally use the same dataset, ensuring quality.</p><p><strong>Why dual markets:</strong> Using only Taiwan data has two issues: (1) history is too short (from 2010), only ~15 years, limiting statistical power; (2) the Taiwan market is heavily concentrated in semiconductors (TSMC alone is ~30% of the weighted index), potentially unrepresentative. Adding nearly a century of US Fama-French data helps determine whether Taiwan results are a special case or a global phenomenon.</p></div>
<h2><span data-lang="zh">2.2 投組建構</span><span data-lang="en">2.2 Portfolio Construction</span></h2>
<div data-lang="zh"><p>投組建構的核心概念是：把股票按「便宜到貴」排序，然後比較最便宜和最貴那組的表現差異。這就像把班上同學按身高排名分成五組，看看最高組和最矮組在籃球比賽中的表現差異——如果最高組總是贏，我們就說「身高溢酬」存在。</p><ul><li><strong>排序指標：</strong>PE（本益比，用來衡量「每賺 1 元需要花多少錢買」）、PB（股價淨值比，衡量「每 1 元淨資產值多少錢」）、殖利率（每年發多少現金股利）、以及三者的複合排名。</li><li><strong>分組方式：</strong>每季末將 30 檔股票按指標排序分為 5 等分（quintile），每組 6 檔。Q1 是最便宜（低 PE/PB 或高殖利率），Q5 是最貴。</li><li><strong>持有期間：</strong>每季再平衡，等權持有——也就是每三個月重新排序一次，每組內的 6 檔股票各投入相同金額。</li><li><strong>HML 建構：</strong>Q1（最便宜）減 Q5（最貴）的月報酬差，即為 HML（High Minus Low）。HML > 0 代表便宜股跑贏貴股。</li><li><strong>標的池：</strong>市值前 30 大上市公司，排除金融業（因 PE/PB 意義不同），確保流動性足以實際執行策略。</li></ul></div><div data-lang="en"><p>The core concept is: sort stocks from "cheap to expensive," then compare performance between the cheapest and most expensive groups. It is like ranking students by height into five groups and comparing basketball performance — if the tallest group always wins, we say a "height premium" exists.</p><ul><li><strong>Sorting metrics:</strong> PE (price-to-earnings, measures "how much you pay per dollar of earnings"), PB (price-to-book, measures "how much 1 dollar of net assets costs"), yield (annual cash dividend), and a composite of all three.</li><li><strong>Grouping:</strong> Quarterly sort of 30 stocks into 5 quintiles, 6 stocks each. Q1 = cheapest (low PE/PB or high yield), Q5 = most expensive.</li><li><strong>Holding:</strong> Quarterly rebalance, equal-weight — re-sort every three months, investing equal amounts in each stock within a group.</li><li><strong>HML construction:</strong> Q1 (cheapest) minus Q5 (most expensive) monthly return = HML (High Minus Low). HML > 0 means cheap beats expensive.</li><li><strong>Universe:</strong> Top 30 listed companies by market cap, excluding financials (PE/PB has different meaning), ensuring sufficient liquidity for practical execution.</li></ul></div>
<h2><span data-lang="zh">2.3 交易成本假設</span><span data-lang="en">2.3 Transaction Cost Assumptions</span></h2>
<div data-lang="zh"><p>本研究採用零交易成本假設進行基準分析，原因如下：(1) 季度再平衡的換手率相對較低（每季只更換排名變動的股票，而非全部重建投組）；(2) 大型股的買賣價差極小（通常 1-2 個 tick）；(3) 學術文獻中的 Fama-French 因子也未扣除交易成本，保持可比性。</p><p>但我們必須提醒讀者：實際交易涉及券商手續費（公定 0.1425%，折扣後約 0.05%）和交易稅（0.3%），每季換股約產生 0.4-0.7% 的成本。如果價值溢酬本身僅有 1-2%，交易成本可能吞噬大部分利潤。這是從「理論溢酬」到「實際可賺的錢」之間必須考慮的落差。</p></div><div data-lang="en"><p>We use zero transaction costs for the baseline analysis because: (1) quarterly rebalancing has relatively low turnover (only stocks whose ranking changed are replaced, not the entire portfolio); (2) large-cap bid-ask spreads are minimal (typically 1-2 ticks); (3) academic Fama-French factors also exclude transaction costs, maintaining comparability.</p><p>However, readers should note: actual trading involves broker commissions (official 0.1425%, ~0.05% with discount) and transaction tax (0.3%), costing ~0.4-0.7% per quarterly rebalance. If the value premium itself is only 1-2%, transaction costs may consume most of the profit. This gap between "theoretical premium" and "actually earnable money" must be considered.</p></div>
<h2><span data-lang="zh">2.4 統計方法</span><span data-lang="en">2.4 Statistical Methods</span></h2>
<div data-lang="zh"><ul><li><strong>HML t 檢定：</strong>檢驗 HML 的平均月報酬是否顯著大於零。由於月報酬資料可能存在自相關，我們使用 Newey-West HAC 標準誤來修正——這就像戴上降噪耳機，過濾掉「假的統計顯著」雜音。</li><li><strong>結構性斷點檢定（Structural Break Test）：</strong>用來偵測 HML 時序中是否在某個時間點發生了「質變」而非「量變」。就像量體溫，如果從 36.5 度突然跳到 38.5 度，那不是隨機波動而是生了病——我們要找出價值溢酬「生病」的確切時間點。</li><li><strong>比例檢定（Proportion Test）：</strong>檢驗價值陷阱的發生比例是否顯著高於某個門檻（20%）。如果超過 20% 的時間便宜股跑輸市場，投資人就需要額外的品質篩選機制。</li><li><strong>Sharpe Ratio 比較：</strong>比較單一因子（只看 PE）與複合因子（PE + PB + 殖利率）的風險調整後報酬，判斷是否值得使用更複雜的選股方法。Sharpe Ratio 越高，代表每承擔一單位風險能獲得越多報酬。</li></ul></div><div data-lang="en"><ul><li><strong>HML t-test:</strong> Tests whether HML mean monthly return is significantly positive. Since monthly returns may exhibit autocorrelation, we use Newey-West HAC standard errors — like wearing noise-canceling headphones to filter out "false statistical significance."</li><li><strong>Structural Break Test:</strong> Detects whether the HML series experienced a qualitative change (not just quantitative fluctuation) at some point. Like measuring body temperature — if it jumps from 36.5 to 38.5, that is not random but illness — we want to find exactly when the value premium 'got sick.'</li><li><strong>Proportion Test:</strong> Tests whether value trap frequency significantly exceeds a threshold (20%). If cheap stocks underperform the market more than 20% of the time, investors need additional quality screening.</li><li><strong>Sharpe Ratio comparison:</strong> Compares risk-adjusted returns of single factor (PE only) vs composite (PE + PB + yield), judging whether the more complex selection method is worthwhile. Higher Sharpe = more return per unit of risk.</li></ul></div><footer>V-010 &copy; 2026</footer></div><script src="js/main.js"></script></body></html>